1. Effects of REDOX in Regulating and Treatment of Metabolic and Inflammatory Cardiovascular Diseases
   Kai Wang et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
2. Altered gut microbial metabolites could mediate the effects of risk factors in Covid‐19
   Jiezhong Chen et al, 2021, Rev Med Virol CrossRef
3. In vitro fermentation of chitooligosaccharides and their effects on human fecal microbial community structure and metabolites
   Xiao-Guo Ji et al, 2021, LWT CrossRef
4. Bioactive lipids and gut microbiota interact to regulate health and disease
   Undurti N. Das, 2021 CrossRef
5. Changes in Intestinal Flora Structure and Metabolites Are Associated With Myocardial Fibrosis in Patients With Persistent Atrial Fibrillation
   Langsha Liu et al, 2021, Front. Nutr. CrossRef
6. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications
   Monika Gawałko et al, 2021 CrossRef
7. Dysbiotic relationship between arthritis and the oral‐gut microbiome. A critical review
   Rubelisa Candido Gomes Oliveira et al, 2022, J of Periodontal Research CrossRef
8. Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives
   Juan Liu et al, 2022, Aging and disease CrossRef
9. Dietary compounds in modulation of gut microbiota-derived metabolites
   Wuwen Feng et al, 2022, Front. Nutr. CrossRef
10. Human circulating bacteria and dysbiosis in non-infectious diseases
    Mohsan Ullah Goraya et al, 2022, Front. Cell. Infect. Microbiol. CrossRef
11. Human microbiome and cardiovascular diseases
    Md Jahangir Alam et al, 2022 CrossRef
12. The role of the gut microbiota in health and cardiovascular diseases
    Lu Wang et al, 2022, Mol Biomed CrossRef
13. Adult hypertensive rats are more prone to gut microflora perturbation and fibrosis in response to moderate restraint stress
    Tiantian Wang et al, 2022, Translational Research CrossRef
14. Diagnostic, Prognostic and Mechanistic Biomarkers of COVID-19 Identified by Mass Spectrometric Metabolomics
    Mélanie Bourgin et al, 2023, Metabolites CrossRef
15. Key elements determining the intestinal region-specific environment of enteric neurons in type 1 diabetes
    Mária Bagyánszki et al, 2023, World J Gastroenterol CrossRef
16. Carotenoids Diet: Digestion, Gut Microbiota Modulation, and Inflammatory Diseases
    Helena R. Rocha et al, 2023, Nutrients CrossRef
17. Gut Microbiota and Integrative Traditional Chinese and Western Medicine in Prevention and Treatment of Heart Failure
    Herong Cui et al, 2023, Phytomedicine CrossRef
18. Role of Human Microbiome in Cardiovascular Disease: Therapeutic Potential and Challenges
    Sathiya Maran et al, 2023 CrossRef
19. Gut microbiome relationship with arrhythmias and conduction blocks: A two-sample Mendelian randomization study
    MengHui Mao et al, 2023, Journal of Electrocardiology CrossRef
20. Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD)
    Maryam Hemmati et al, 2023, Life Sciences CrossRef
21. The relationship between atrial fibrillation and NLRP3 inflammasome: a gut microbiota perspective
    Yaxuan Xing et al, 2023, Front. Immunol. CrossRef
22. Reduced bacterial resistance antibiotics with improved microbiota tolerance in human intestinal: Molecular design and mechanism analysis
    Meijin Du et al, 2023, Journal of Hazardous Materials CrossRef
23. Kidney-tonifying blood-activating decoction delays ventricular remodeling in rats with chronic heart failure by regulating gut microbiota and metabolites and p38 mitogen-activated protein kinase/p65 nuclear factor kappa-B/aquaporin-4 signaling pathway
    Rui Xu et al, 2024, Journal of Ethnopharmacology CrossRef
24. Gut microbiome and metabolomic profiles reveal the antiatherosclerotic effect of indole-3-carbinol in high-choline-fed ApoE−/− mice
    Yuan He et al, 2024, Phytomedicine CrossRef
25. Chemical interplay between gut microbiota and epigenetics: Implications in circadian biology
    Samskrathi Aravinda Sharma et al, 2024, Cell Chemical Biology CrossRef
26. The Role of Gut Dysbiosis in Cardiovascular Diseases
    Vikrant Rai et al, 2024 CrossRef
27. Microbiota alterations associated with vascular diseases: postbiotics as a next-generation magic bullet for gut-vascular axis
    Lorenzo Flori et al, 2024, Pharmacological Research CrossRef
28. Aging‐associated atrial fibrillation: A comprehensive review focusing on the potential mechanisms
    Meng‐Fei Wang et al, 2024, Aging Cell CrossRef
29. Omega-3 polyunsaturated fatty acids, especially DHA and EPA, remold gut microbiota to suppress inflammation in rabbits with atherosclerosis
    Xinwei Zhang et al, 2024, Animals and Zoonoses CrossRef
30. Role of Gut Microbial Metabolites in Cardiovascular Diseases—Current Insights and the Road Ahead
    Sayantap Datta et al, 2024, IJMS CrossRef
31. Exploring synergistic effects of Achyranthes bidentata Blume and Paeonia lactiflora Pall. on hypertension with liver yang hyperactivity using the multidisciplinary integrative strategy
    Yanyan Zhang et al, 2024, Heliyon CrossRef
32. Gut Microbiota and Their Metabolites as Modulators of Vascular Complications in Diabetes
    Meng Duan et al, 2025, HM CrossRef
33. Identifying the Involvement of Gut Microbiota in Retinal Vein Occlusion by Mendelian Randomization and Genetic Correlation Analysis
    Shizhen Lei et al, 2025, Trans. Vis. Sci. Tech. CrossRef